Figure 1 – Geographical area covered by responding surgeons/MDTs

References

1. Thyroid cancer incidence statistics | Cancer Research UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/thyroid-cancer/incidence#heading-Three. Accessed December 16, 2019.
2. Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K. Patients’ experiences of diagnosis and management of papillary thyroid microcarcinoma: A qualitative study. BMC Cancer . 2018;18(1):1-10. doi:10.1186/s12885-018-4152-9
3. Sipos JA, Mazzaferri EL. Thyroid Cancer Epidemiology and Prognostic Variables. Clin Oncol . 2010;22(6):395-404. doi:10.1016/J.CLON.2010.05.004
4. Roti E, degli Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study.Eur J Endocrinol . 2008;159(6):659-673. doi:10.1530/EJE-07-0896
5. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid . 2016;26(1):1-133. doi:10.1089/thy.2015.0020
6. Perros P, Boelaert K, Colley S, et al. British Thyoid Assoication Guidelines for the Management of Thyroid Cancer. Clin Endocrinol (Oxf) . 2014;81:1-122. doi:10.1111/cen.12515
7. Chadwick D, Kinsman R, Walton P. The British Association of Endocrine & Thyroid Surgeons Fourth National Audit Report .; 2012.
8. Ullmann TM, Gray KD, Stefanova D, et al. The 2015 American Thyroid Association guidelines are associated with an increasing rate of hemithyroidectomy for thyroid cancer. Surgery . 2019;166(3):349-355. doi:10.1016/j.surg.2019.03.002
9. Hirshoren N, Kaganov K, Weinberger JM, et al. Thyroidectomy practice after implementation of the 2015 American thyroid association guidelines on surgical options for patients with well-differentiated thyroid carcinoma. JAMA Otolaryngol - Head Neck Surg . 2018;144(5):427-432. doi:10.1001/jamaoto.2018.0042
10. Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer . 2013;119(2):259-265. doi:10.1002/cncr.27721
11. Haymart MR, Banerjee M, Yang D, et al. Variation in the management of thyroid cancer. J Clin Endocrinol Metab . 2013;98(5):2001-2008. doi:10.1210/jc.2012-3355
12. Haymart MR, Banerjee M, Yang D, et al. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.Ann Surg . 2013;258(2):354-358. doi:10.1097/SLA.0b013e31826c8915
13. Papaleontiou M, Banerjee M, Yang D, Sisson JC, Koenig RJ, Haymart MR. Factors that influence radioactive iodine use for thyroid cancer.Thyroid . 2013;23(2):219-224. doi:10.1089/thy.2012.0380
14. BAETS. De-anonymised numbers 2016. http://www.baets.org.uk/wp-content/uploads/Deanonymised-BAETS-Surgeon-Data-2016.pdf. Published 2016.
15. Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA. Exploring the relationship between patient age and cancer- Specific survival in papillary thyroid cancer: Rethinking current staging systems. J Clin Oncol . 2016;34(36):4415-4420. doi:10.1200/JCO.2016.68.9372
16. IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01398085. Accessed July 10, 2019.
17. Adam MA, Pura J, Gu L, et al. Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival. Ann Surg . 2014;260(4):601-607. doi:10.1097/SLA.0000000000000925
18. Haigh PI, Urbach DR, Rotstein LE. Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer. Ann Surg Oncol . 2005;12(1):81-89. doi:10.1007/s10434-004-1165-1
19. Vargas-Pinto S, Romero Arenas MA. Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review. J Surg Res . 2019;242:244-251. doi:10.1016/j.jss.2019.04.036
20. Harries V, Wang LY, McGill M, et al. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? In: Surgery (United States) . Mosby Inc.; 2019. doi:10.1016/j.surg.2019.03.031
21. Geron Y, Benbassat C, Shteinshneider M, et al. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis. Thyroid . 2019;29(4):513-522. doi:10.1089/thy.2018.0547
22. Nickel B, Semsarian C, Moynihan R, et al. Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study. BMJ Open . 2019;9(2):e025820. doi:10.1136/bmjopen-2018-025820
23. Stacey D, Légaré F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev . April 2017. doi:10.1002/14651858.CD001431.pub5
24. Hoffmann TC, Légaré F, Simmons MB, et al. Shared decision making: what do clinicians need to know and why should they bother? Med J Aust . 2014;201(1):35-39. doi:10.5694/mja14.00002